Innovation Growth Board

Our Innovation Growth Board members are leaders in investment, entrepreneurial, and industrial communities.

The Innovation Growth Board provides independent advice on strategy, business development, technology and market opportunity, investment approach, human resource acquisition, and product development.

Paul LaViolette

Managing partner, chief operating officer, and innovation growth board chairman, SV Health Investors
Earl (Duke) Collier

President, The Braxton Company and Innovation Growth
Joe Cunningham, MD

Partner and managing director, Santé Ventures
Jean-François Formela, MD

Partner, Atlas Venture
Adele Gulfo

Chief executive officer, Biopharma Commercial Unit at Sumitomo Pharma America
Reid Huber, PhD

Partner, Third Rock Ventures
Andy Hurd

Operating partner, Cressey and Company
Keith Kerman, MD

Operating partner and senior advisor, The Riverside Company
Robert Kingston, PhD

Chief academic officer, Massachusetts General Hospital
Adam Koppel, MD, PhD

Managing director, Bain Capital
John Lepore, MD

Senior vice president, GSK
Barbara Lubash

Director and Advisor for corporate and non-profit boards
Amir Nashat

Managing partner, Polaris’ Boston office
Russ Richmond, MD

Physician and entrepreneur
Alfred Sandrock, MD, PhD

CEO and a board member, Voyager Therapeutics
Sue Siegel

Chief innovation officer, GE and CEO, GE Ventures
Paula Ness Speers

Co-founder, Health Advances

Our team

Commercialization Council